Search Results - Annunziata MC
- Showing 1 - 2 results of 2
-
1
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report by Martora F, Annunziata MC, Potestio L, Battista T, Ruggiero A, Megna M
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience by Martora F, Megna M, Battista T, Potestio L, Annunziata MC, Marasca C, Villani A, Fabbrocini G
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book